LOCAL 12 - Search Results
CINCINNATI, Ohio (Liz Bonis) -- David Shuller has a family history of prostate cancer.
He says, "My father died of prostate cancer at 68 for me, I'm 63 so I am determined to beat this."
"This" was a suspicious area found after an initial exam, ultrasound, MRI and biopsy. The biopsy was done with MRI guidance with the help of what's called Fusion Targeted Biopsy Technology.
This specific machine has a GPS device it can fuse the two images, the MRI, and ultrasound, and the targets that were seen on MRI, can be then localized for biopsy.”
Doctor Sadhna Verma was one of the initial researchers who helped get this guided biopsy technology approved for use by the Food and Drug Administration.
She now uses a high tech software system with it so along with a clinical team of cancer experts they can determine how likely it is that prostate cancer will spread.
What makes this unique is that it gives them certain advantages, almost like a woman when she has mammograms. You can compare year to year, you can use different techniques, and together that gets the proper diagnosis and treatment, but more importantly it allows you to be followed, and notice changes for a number of years.
MRI can be a very important tool in following these patients who may have a very small insignificant tumor.